HLS Therapeutics Inc.

HLS.TOTSXHealthcare● Active

$4.41

$-0.06(-1.34%)

Market Cap$137917017

P/E Ratio—

52W High$5.765

52W Low$0.001

Avg Volume7K

Open$4.40

Beta0.85

Net Income Financials Revenue

HLS Therapeutics Inc. (HLS.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

HLS.TO · net income · updated Jun 8, 2026

Core profitability metrics

HLS.TO · net income · margin · TTM · CAGR

Net income was −$12.6M for FY2025 (fiscal year ending 2025-12-31), up 35.7% year-over-year. Net profit margin was -22.4%. Based on available data, HLS Therapeutics Inc. has been profitable since at least 2011.

FY2025 Net Income−$12.6M▲ +35.7% YoY

Trailing 12M (TTM)−$10.3Mtrailing 4 quarters sum

Net Profit Margin-22.4%−$12.6M ÷ $56.5M

YoY Change+35.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · HLS.TO net income history · HLS.TO profit margin

Annual net income data

HLS.TO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$12.6M▲ +35.7%-22.4%$56.5M

FY2024Loss−$19.7M▲ +28.6%-34.7%$56.6M

FY2023Loss−$27.5M▼ 16.7%-43.6%$63.1M

FY2022Loss−$23.6M▼ 79.9%-38.4%$61.5M

FY2021Loss−$13.1M▲ +14.4%-21.9%$60.0M

Net income vs peers (Healthcare)

HLS.TO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

HLS Therapeutics Inc.YOU

HLS.TO

−$12.6M+35.7%-22.4%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

HLS Therapeutics Inc. (HLS.TO) reported net income of −$12.6M for FY2025 (fiscal year ending 2025-12-31), up 35.7% year-over-year. The net profit margin was -22.4% — meaning the company kept $-0.22 of every dollar of revenue as profit.

Based on available data, HLS Therapeutics Inc. has been profitable since at least 2011. Net income reached a peak of $16.9M in FY2012. Data available for 15 fiscal years.

HLS Therapeutics Inc.'s net profit margin was -22.4% for FY2025, based on the latest annual results.

Investors sometimes search for "HLS Therapeutics Inc. net worth" — the company's market capitalization is a separate figure from HLS.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

HLS.TO net income · 4 questions

HLS Therapeutics Inc. is not currently profitable on an annual basis. The company reported a net loss of $12.6M for FY2025.

is HLS.TO profitabledoes HLS.TO make a profitHLS.TO profitabilityHLS.TO profitable company

▸ Source: FMP /income-statement · GAAP · HLS Therapeutics Inc. · HLS Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026